AstraZeneca says cancer drug Imfinzi improves survival chances in late-stage trial 10/03/2023 (VOVWORLD) - Lung cancer patients treated with AstraZeneca's immunotherapy Imfinzi pre- and post-surgery in a trial lived significantly longer without the disease progressing or recurring than those treated with chemotherapy...